Rigid-DMN Flag: A Resting-State Response-Control Marker for Pediatric ADHD
An MRI tool that measures how a child's brain handles impulse control to identify ADHD risk.
A resting-state fMRI module that quantifies how strongly and how rigidly a child's default mode network is coupled to task-control networks, returning a response-control risk profile — the over-integrated, low-variability pattern linked to impulsive commission errors in children with ADHD.
Concept
A software module for specialized pediatric neurodevelopmental assessment centers and ADHD trial teams. From a short resting-state scan — no in-scanner task, which removes the usual compliance failure point for children — it computes participation coefficient metrics (mean and variability) for default mode network regions relative to fronto-parietal, salience/cingulo-opercular, and somatomotor networks, and returns a "response-control profile": flagging the high, stable DMN coupling pattern that predicted higher commission-error rates. Two concrete uses: objective severity stratification during assessment (identifying which children carry the most impulsive-error-prone profile), and enrichment/stratification in pediatric ADHD trials where response inhibition is an endpoint. The wedge: one measurable, behaviorally-anchored network marker of response-control deficit.
Why now
In 43 children with ADHD versus 43 age-matched typically developing children, the ADHD group showed significantly higher mean participation coefficient (greater inter-network integration), with specifically increased DMN–fronto-parietal coupling; higher DMN–salience and DMN–somatomotor integration, and reduced variability of that integration, correlated with higher commission-error rates on go/no-go, and ADHD children also showed poorer inhibition and more variable Go responses. Converging structural evidence from the 129-study diffusion meta-analysis shows white-matter connectivity alterations in ADHD are associated with symptom severity and cognitive deficits, indicating connectivity metrics carry clinically meaningful signal. Existing objective ADHD tests (continuous-performance-type tools) capture behavior only; this adds the mechanistic network layer, measurable at rest, ready for validation in the specialized centers that already scan children.
Written by GLM · 13 Oct 2026
AI assessment
A focused diagnostic module that leverages resting-state fMRI to provide a mechanistic, behaviorally-linked marker for impulsivity in pediatric ADHD, offering high value for clinical trial stratification.
- Evidence strength 4/5
- The idea is directly grounded in a specific study showing that DMN participation coefficients and their variability correlate with commission errors in children, though the sample size (n=86) is modest.
- Market pull 4/5
- Pharma trial teams have a high willingness to pay for enrichment tools that reduce noise in response-inhibition endpoints, and specialized centers seek objective markers to supplement behavioral tests.
- Novelty & moat 4/5
- Unlike the listed catalog ideas which focus on structural white matter or gray matter volume, this targets functional network integration (participation coefficients) as a dynamic marker of response control.
- Feasibility 3/5
- While the software analysis is straightforward, the requirement for fMRI scans in children remains a significant operational hurdle due to cost and motion artifacts.
- Wedge clarity 5/5
- The wedge is exceptionally sharp: a single resting-state marker specifically linked to commission-error risk, avoiding the compliance issues of in-scanner tasks.
- Simplicity / focus 5/5
- The product is a single-purpose analysis module with a clear input (rs-fMRI) and a clear output (response-control risk profile).
Scored by Gemma 4 · 13 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Qbtechcompany
Maker of the FDA-cleared QbTest for objective ADHD assessment; a neural response-control layer is a natural next product extension for its objective-testing portfolio.
- Child Mind Instituteorganization
Provides ADHD clinical care and research; a resting-state marker of response-control severity enriches both its assessment pathway and its research studies.
- Kennedy Krieger Instituteorganization
A pediatric neurodevelopmental assessment and imaging research center; the marker offers an objective stratifier for its ADHD patient populations and studies.
- Supernus Pharmaceuticalscompany
Develops ADHD therapies (Qelbree); a validated stratification biomarker for response-control deficits helps enrich pediatric trials with impulsive-error-prone participants and supports inhibition endpoints.
Research it builds on
- White matter alterations in Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review of 129 diffusion imaging studies with meta-analysisValeria Parlatini, Takashi Itahashi, Yeji Lee et al. · 2023 · 96 citationsAll ideas from this paper →
- Increased integration between default mode and task-relevant networks in children with ADHD is associated with impaired response controlKelly A. Duffy, Keri Shiels Rosch, Mary Beth Nebel et al. · 2021 · 44 citationsAll ideas from this paper →